Boosting the Economy and Driving Innovation
Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26.1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Learn MoreLatest Opportunities with SBIR
-
NCI STEP Deadline ApproachingApply for SBIR/STTR application support and entrepreneurship training through NCI STEP by at Friday, May 15, 2026.
-
Upcoming ASGCT Poster PresentationConnect with the NCI SBIR team during the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting.
-
NCI SBIR at NucleateLearn about NCI SBIR funding opportunities and commercialization support for biotech startups during the Nucleate workshop in Boston
Success Story: Illumina
Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale. Illumina used NCI SBIR funding to develop their next generation sequencing technology.
Learn More
Why SBIR?